Jen Herbach
Jen Herbach is the founder and CEO of Adventris Pharmaceuticals, the biotech startup discussed in Founder Mode: Jen Herbach, Founder & CEO, Adventris Pharmaceuticals. The source presents her as a science-trained life-sciences operator who considered becoming an oncologist, later went to graduate school and business school, and spent her career helping bring novel oncology drugs to market.
Her founder story links technical conviction to company control. After Brian Chesky’s Founder Mode talk, Herbach stopped treating the lab science as something she should avoid because she was the business-side founder. She moved closer to daily scientific work, created daily end-of-day standups, raised accountability, and let the team change around that operating standard.
The same episode makes Herbach a Biotech Founder Control case. She says Y Combinator advice to use SAFEs and reject an investor board seat later helped Adventris preserve scientific decision-making when an investor disagreed with the company’s product direction. In her telling, the company could listen to the feedback, reject it on scientific and product grounds, and later improve its vaccine delivery platform without waiting for external board approval.
Key Claims
- Herbach founded Adventris with a college roommate and lab partner who became an oncologist.
- She frames cancer vaccines as a way to help the immune system recognize cancer cells it had failed to see.
- Her founder-mode shift was concrete: more detail-level scientific involvement, daily standups, clearer accountability, and eventual team changes.
- Her board-control stance is tied to clinical and patient judgment, not only ownership economics.
Connections
- Adventris Pharmaceuticals, Cancer Vaccine Platform, and KRAS Oncology Target - company and scientific strategy.
- Y Combinator, The Social Radars, Jessica Livingston, and Carolyn Levy - accelerator and interview context.
- Founder Mode, Founder Proximity, Founder Delegation Discipline, Startup Governance, and Biotech Founder Control - operating and governance concepts extended by the source.